Skip to main content
. 2021 Jul 14;8:707701. doi: 10.3389/fcvm.2021.707701

Table 4.

Subgroup analysis.

N All-cause mortality HR (95% CI) P-value P for log likelihood ratio test Cardiovascular mortality HR (95% CI) P-value P for log likelihood ratio test
Cutoff value, mmol/l <158 ≥158 <190 ≥190
Age
≥65 4,323 0.95 (0.93, 0.98) <0.001 1.00 (0.98, 1.03) 0.769 0.021 1.00 (0.96, 1.04) 0.896 1.02 (0.94, 1.11) 0.669 0.777
<65 7,846 0.93 (0.89, 0.97) <0.001 1.03 (1.01, 1.06) 0.018 <0.001 0.95 (0.89, 1.02) 0.164 1.11 (1.07, 1.15) <0.001 0.002
Gender
Male 5,783 0.91 (0.88, 0.93) <0.001 1.04 (1.01, 1.07) 0.014 <0.001 0.95 (0.91, 1.00) 0.046 1.12 (1.07, 1.17) <0.001 <0.001
Female 6,386 0.97 (0.94, 1.01) 0.117 1.01 (0.98, 1.04) 0.396 0.149 1.01 (0.96, 1.07) 0.63 1.03 (0.94, 1.13) 0.517 0.787
Race
Non-white 6,757 0.93 (0.90, 0.96) <0.001 1.04 (1.01, 1.07) 0.003 <0.001 0.97 (0.93, 1.02) 0.204 1.11 (1.06, 1.17) <0.001 0.002
White 5,412 0.95 (0.92, 0.98) <0.001 1.01 (0.98, 1.04) 0.462 0.015 1.00 (0.95, 1.05) 0.999 1.06 (0.98, 1.15) 0.157 0.327
Lipid-lowering drugs
No 9,768 0.93 (0.91, 0.96) <0.001 1.02 (1.00, 1.05) 0.034 <0.001 0.98 (0.95, 1.02) 0.397 1.09 (1.04, 1.14) <0.001 0.013
Yes 2,401 0.96 (0.91, 1.00) 0.061 1.03 (0.98, 1.09) 0.25 0.086 0.99 (0.91, 1.07) 0.779 1.11 (1.01, 1.22) 0.024 0.136
Body mass index, kg/m2
<25 2,422 0.92 (0.88, 0.95) <0.001 1.03 (0.98, 1.08) 0.227 0.002 0.98 (0.93, 1.05) 0.6 1.07 (0.93, 1.23) 0.323 0.346
≥25 9,491 0.95 (0.92, 0.98) <0.001 1.03 (1.00, 1.05) 0.023 <0.001 0.99 (0.95, 1.03) 0.699 1.10 (1.05, 1.15) <0.001 0.009

When analyzing a subgroup variable, age, gender, race, smoking, body mass index, systolic blood pressure, diabetes, and medicine use (antihypertensive drugs, hypoglycemic agents, and lipid-lowering drugs) were all adjusted except the variable itself.